GT BIOPHARMA, INC. Operating Income
GT BIOPHARMA, INC. (GTBP) reported Operating Income of -$4.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- GT BIOPHARMA, INC. operating income (loss) for the quarter ending 2026-06-30 was -$4.51M.
- GT BIOPHARMA, INC. operating income (loss) for the quarter ending 2026-03-31 was -$2.85M.
- GT BIOPHARMA, INC. operating income (loss) for the quarter ending 2025-12-31 was -$5.59M.
- GT BIOPHARMA, INC. operating income (loss) for the quarter ending 2025-09-30 was -$3.38M.
- GT BIOPHARMA, INC. operating income (loss) for fiscal 2025 was -$12.42M.
- GT BIOPHARMA, INC. operating income (loss) for fiscal 2024 was -$14.36M.
- GT BIOPHARMA, INC. operating income (loss) for fiscal 2023 was -$13.58M.
- GT BIOPHARMA, INC. operating income (loss) for fiscal 2022 was -$21.26M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.51M 10-Q · filed 2026-08-14 | -$7.36M 10-Q · filed 2026-08-14 | -$12.96M derived: sum of 3 quarters · filed 2026-08-14 | -$16.34M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$2.85M 10-Q · filed 2026-05-15 | -$8.44M derived: sum of 2 quarters · filed 2026-05-15 | -$11.82M derived: sum of 3 quarters · filed 2026-05-15 | -$13.34M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$5.59M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | -$8.98M derived: sum of 2 quarters · filed 2026-03-06 | -$10.49M derived: sum of 3 quarters · filed 2026-08-14 | -$12.42M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$3.38M 10-Q/A · filed 2026-03-06 | -$4.89M derived: sum of 2 quarters · filed 2026-08-14 | -$6.83M 10-Q/A · filed 2026-03-06 | -$10.59M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$1.51M 10-Q · filed 2026-08-14 | -$3.44M 10-Q · filed 2026-08-14 | -$7.21M derived: sum of 3 quarters · filed 2026-08-14 | -$10.81M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$1.93M 10-Q · filed 2026-05-15 | -$5.70M derived: sum of 2 quarters · filed 2026-05-15 | -$9.30M derived: sum of 3 quarters · filed 2026-05-15 | -$13.21M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$3.76M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | -$7.37M derived: sum of 2 quarters · filed 2026-03-06 | -$11.27M derived: sum of 3 quarters · filed 2026-03-06 | -$14.36M 10-K · filed 2026-03-02 | ||
| 2024-09-30 | -$3.60M 10-Q/A · filed 2026-03-06 | -$7.51M derived: sum of 2 quarters · filed 2026-03-06 | -$10.60M 10-Q/A · filed 2026-03-06 | -$13.77M derived: sum of 4 quarters · filed 2026-03-06 | ||
| 2024-06-30 | -$3.91M 10-Q/A · filed 2026-03-06 | -$7.00M 10-Q/A · filed 2026-03-06 | -$10.16M derived: sum of 3 quarters · filed 2026-03-06 | -$13.29M derived: sum of 4 quarters · filed 2026-03-06 | ||
| 2024-03-31 | -$3.09M 10-Q · filed 2025-05-15 | -$6.26M derived: sum of 2 quarters · filed 2025-05-15 | -$9.38M derived: sum of 3 quarters · filed 2025-05-15 | -$13.00M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$6.29M derived: sum of 2 quarters · filed 2025-02-21 | -$9.91M derived: sum of 3 quarters · filed 2025-02-21 | -$13.58M 10-K · filed 2025-02-21 | ||
| 2023-09-30 | -$3.12M 10-Q · filed 2024-11-14 | -$6.74M derived: sum of 2 quarters · filed 2024-11-14 | -$10.41M 10-Q · filed 2024-11-14 | -$16.19M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$3.62M 10-Q · filed 2024-08-14 | -$7.29M 10-Q · filed 2024-08-14 | -$13.06M derived: sum of 3 quarters · filed 2024-08-14 | -$20.09M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$3.67M 10-Q · filed 2024-05-15 | -$9.44M derived: sum of 2 quarters · filed 2024-05-15 | -$16.47M derived: sum of 3 quarters · filed 2024-05-15 | -$19.48M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$12.80M derived: sum of 2 quarters · filed 2024-03-26 | -$15.81M derived: sum of 3 quarters · filed 2024-03-26 | -$21.26M 10-K · filed 2024-03-26 | ||
| 2022-09-30 | -$7.02M 10-Q · filed 2023-11-01 | -$10.04M derived: sum of 2 quarters · filed 2023-11-01 | -$15.48M 10-Q · filed 2023-11-01 | -$33.66M derived: sum of 4 quarters · filed 2023-11-01 | ||
| 2022-06-30 | -$3.01M 10-Q · filed 2023-08-07 | -$8.46M 10-Q · filed 2023-08-07 | -$26.63M derived: sum of 3 quarters · filed 2023-08-07 | -$32.59M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | -$5.44M 10-Q · filed 2023-05-15 | -$23.62M derived: sum of 2 quarters · filed 2023-05-15 | -$29.57M derived: sum of 3 quarters · filed 2023-05-15 | -$33.95M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$24.13M derived: sum of 2 quarters · filed 2023-03-30 | -$28.51M derived: sum of 3 quarters · filed 2023-03-30 | -$57.52M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$5.95M 10-Q · filed 2022-10-31 | -$10.34M derived: sum of 2 quarters · filed 2022-10-31 | -$39.34M 10-Q · filed 2022-10-31 | -$41.53M derived: sum of 4 quarters · filed 2022-10-31 | ||
| 2021-06-30 | -$4.38M 10-Q · filed 2022-08-15 | -$33.38M 10-Q · filed 2022-08-15 | -$35.57M derived: sum of 3 quarters · filed 2022-08-15 | -$37.52M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | -$29.00M 10-Q · filed 2022-05-16 | $29.00M 10-Q · filed 2021-05-17 | -$31.19M derived: sum of 2 quarters · filed 2022-05-16 | -$33.14M derived: sum of 3 quarters · filed 2022-05-16 | -$34.70M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$4.14M derived: sum of 2 quarters · filed 2022-03-28 | -$5.69M derived: sum of 3 quarters · filed 2022-03-28 | -$6.76M 10-K · filed 2022-03-28 | $6.76M 10-K · filed 2021-04-16 | |
| 2020-09-30 | -$1.95M 10-Q · filed 2020-11-13 | -$3.50M derived: sum of 2 quarters · filed 2020-11-13 | -$4.57M 10-Q · filed 2020-11-13 | $28.81M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2020-06-30 | -$1.56M 10-Q/A · filed 2020-08-18 | -$2.63M 10-Q/A · filed 2020-08-18 | $30.76M derived: sum of 3 quarters · filed 2021-05-17 | $21.90M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2020-03-31 | $1.07M 10-Q · filed 2021-05-17 | -$1.07M 10-Q · filed 2020-05-15 | $32.32M derived: sum of 2 quarters · filed 2021-05-17 | $23.46M derived: sum of 3 quarters · filed 2021-05-17 | $21.18M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $31.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | $22.39M derived: sum of 2 quarters · filed 2021-04-16 | $20.11M derived: sum of 3 quarters · filed 2021-04-16 | $16.06M 10-K · filed 2021-04-16 | -$16.06M 10-K · filed 2020-03-27 | |
| 2019-09-30 | -$8.86M 10-Q · filed 2020-11-13 | -$11.13M derived: sum of 2 quarters · filed 2020-11-13 | -$15.19M 10-Q · filed 2020-11-13 | -$18.28M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | -$2.28M 10-Q/A · filed 2020-08-18 | -$6.33M 10-Q/A · filed 2020-08-18 | -$9.43M derived: sum of 3 quarters · filed 2020-08-18 | -$244.09M derived: sum of 4 quarters · filed 2020-08-18 | ||
| 2019-03-31 | -$4.06M 10-Q · filed 2020-05-15 | -$7.15M derived: sum of 2 quarters · filed 2020-05-15 | -$241.81M derived: sum of 3 quarters · filed 2020-05-15 | -$246.97M derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | -$3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$237.75M derived: sum of 2 quarters · filed 2020-03-27 | -$242.91M derived: sum of 3 quarters · filed 2020-03-27 | -$250.07M 10-K · filed 2020-03-27 | ||
| 2018-09-30 | -$234.66M 10-Q · filed 2019-11-14 | -$239.82M derived: sum of 2 quarters · filed 2019-11-14 | -$246.98M 10-Q · filed 2019-11-14 | -$252.87M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$5.16M 10-Q · filed 2019-08-14 | -$12.32M 10-Q · filed 2019-08-14 | -$18.21M derived: sum of 3 quarters · filed 2019-08-14 | -$145.06M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$7.16M 10-Q · filed 2019-05-15 | -$13.05M derived: sum of 2 quarters · filed 2019-05-15 | -$139.91M derived: sum of 3 quarters · filed 2019-05-15 | -$141.19M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | -$5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$132.75M derived: sum of 2 quarters · filed 2019-03-29 | -$134.03M derived: sum of 3 quarters · filed 2019-03-29 | -$135.57M 10-K · filed 2019-03-29 | ||
| 2017-09-30 | -$126.86M 10-Q · filed 2018-11-14 | -$128.14M derived: sum of 2 quarters · filed 2018-11-14 | -$129.68M 10-Q · filed 2018-11-14 | -$130.50M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | -$1.28M 10-Q · filed 2018-08-14 | -$2.82M 10-Q · filed 2018-08-14 | -$3.65M derived: sum of 3 quarters · filed 2018-08-14 | -$6.17M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | -$1.54M 10-Q · filed 2018-05-15 | -$2.36M derived: sum of 2 quarters · filed 2018-05-15 | -$4.89M derived: sum of 3 quarters · filed 2018-05-15 | -$7.01M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$822.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | -$3.35M derived: sum of 2 quarters · filed 2018-03-01 | -$5.47M derived: sum of 3 quarters · filed 2018-03-01 | -$9.37M 10-K · filed 2018-03-01 | ||
| 2016-09-30 | -$2.53M 10-Q/A · filed 2018-02-28 | -$4.65M derived: sum of 2 quarters · filed 2018-02-28 | -$8.55M 10-Q/A · filed 2018-02-28 | -$11.46M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2016-06-30 | -$2.12M 10-Q/A · filed 2018-02-28 | -$6.02M 10-Q/A · filed 2018-02-28 | -$8.93M derived: sum of 3 quarters · filed 2018-02-28 | -$11.71M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2016-03-31 | -$3.90M 10-Q/A · filed 2018-02-28 | -$6.81M derived: sum of 2 quarters · filed 2018-02-28 | -$9.59M derived: sum of 3 quarters · filed 2018-02-28 | -$11.02M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-12-31 | -$2.91M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | -$5.68M derived: sum of 2 quarters · filed 2018-02-28 | -$7.12M derived: sum of 3 quarters · filed 2018-02-28 | -$8.93M 10-K/A · filed 2018-02-28 | ||
| 2015-09-30 | -$2.78M 10-Q/A · filed 2018-02-28 | -$4.21M derived: sum of 2 quarters · filed 2018-02-28 | -$6.02M 10-Q/A · filed 2018-02-28 | -$7.66M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-06-30 | -$1.43M 10-Q/A · filed 2018-02-28 | -$3.24M 10-Q/A · filed 2018-02-28 | -$4.88M derived: sum of 3 quarters · filed 2018-02-28 | -$5.43M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-03-31 | -$1.81M 10-Q/A · filed 2018-02-28 | -$3.45M derived: sum of 2 quarters · filed 2018-02-28 | -$4.00M derived: sum of 3 quarters · filed 2018-02-28 | -$4.11M derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2014-12-31 | -$1.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | -$2.19M derived: sum of 2 quarters · filed 2018-02-28 | -$2.29M derived: sum of 3 quarters · filed 2018-02-28 | -$2.40M 10-K/A · filed 2018-02-28 | ||
| 2014-09-30 | -$549.00K 10-Q · filed 2015-11-13 | -$653.00K derived: sum of 2 quarters · filed 2015-11-13 | -$754.00K 10-Q · filed 2015-11-13 | -$986.00K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | -$104.00K 10-Q · filed 2015-08-14 | -$205.00K 10-Q · filed 2015-08-14 | -$437.00K derived: sum of 3 quarters · filed 2015-08-14 | -$577.00K derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | -$101.00K 10-Q · filed 2015-05-14 | -$333.00K derived: sum of 2 quarters · filed 2015-05-14 | -$473.00K derived: sum of 3 quarters · filed 2015-05-14 | -$547.00K derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2013-12-31 | -$232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$372.00K derived: sum of 2 quarters · filed 2015-03-31 | -$446.00K derived: sum of 3 quarters · filed 2015-03-31 | -$793.00K 10-K · filed 2015-03-31 | ||
| 2013-09-30 | -$140.00K 10-Q · filed 2014-12-17 | -$214.00K derived: sum of 2 quarters · filed 2015-01-08 | -$561.00K 10-Q · filed 2015-01-08 | -$1.30M derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2013-06-30 | -$74.00K 10-Q · filed 2015-01-08 | -$421.00K 10-Q · filed 2015-01-08 | -$1.16M derived: sum of 3 quarters · filed 2015-01-08 | -$2.51M derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2013-03-31 | -$347.00K 10-Q · filed 2015-01-08 | -$1.09M derived: sum of 2 quarters · filed 2015-01-08 | -$2.44M derived: sum of 3 quarters · filed 2015-01-08 | -$3.47M derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2012-12-31 | -$739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | -$2.09M derived: sum of 2 quarters · filed 2015-01-08 | -$3.12M derived: sum of 3 quarters · filed 2015-01-08 | -$3.51M 10-K · filed 2015-01-08 | ||
| 2012-09-30 | -$1.35M 10-Q · filed 2014-12-17 | -$2.38M derived: sum of 2 quarters · filed 2014-12-17 | -$2.77M 10-Q · filed 2014-12-17 | -$3.82M derived: sum of 4 quarters · filed 2014-12-17 | ||
| 2012-06-30 | -$1.03M 10-Q · filed 2014-12-12 | -$1.43M 10-Q · filed 2014-12-12 | -$2.47M derived: sum of 3 quarters · filed 2014-12-12 | -$3.02M derived: sum of 4 quarters · filed 2014-12-12 | ||
| 2012-03-31 | -$396.00K 10-Q · filed 2014-12-10 | -$1.44M derived: sum of 2 quarters · filed 2014-12-10 | -$1.99M derived: sum of 3 quarters · filed 2014-12-10 | -$2.47M derived: sum of 4 quarters · filed 2014-12-10 | ||
| 2011-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | -$1.59M derived: sum of 2 quarters · filed 2014-11-18 | -$2.07M derived: sum of 3 quarters · filed 2014-11-18 | -$3.93M 10-K · filed 2014-11-18 | ||
| 2011-09-30 | -$541.00K 10-Q · filed 2012-11-21 | -$1.02M derived: sum of 2 quarters · filed 2012-11-21 | -$2.88M 10-Q · filed 2012-11-21 | -$3.41M derived: sum of 4 quarters · filed 2012-11-21 | ||
| 2011-06-30 | -$481.00K 10-Q/A · filed 2012-09-13 | -$2.34M 10-Q/A · filed 2012-09-13 | -$2.87M derived: sum of 3 quarters · filed 2012-09-13 | -$3.52M derived: sum of 4 quarters · filed 2012-09-13 | ||
| 2011-03-31 | -$1.86M 10-Q · filed 2012-05-21 | -$2.38M derived: sum of 2 quarters · filed 2012-05-21 | -$3.04M derived: sum of 3 quarters · filed 2012-05-21 | -$3.42M derived: sum of 4 quarters · filed 2012-05-21 | ||
| 2010-12-31 | -$527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$1.18M derived: sum of 2 quarters · filed 2012-04-16 | -$1.57M derived: sum of 3 quarters · filed 2012-04-16 | -$2.50M 10-K · filed 2012-04-16 | ||
| 2010-09-30 | -$654.00K 10-Q · filed 2011-11-21 | -$1.04M derived: sum of 2 quarters · filed 2011-11-21 | -$1.97M 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | -$386.00K 10-Q/A · filed 2011-09-12 | -$1.32M 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |